Diagnostic value of PSA and related parameters for prostate cancer with PSA<4.0 ng/ml
HUANG Shun-tan1 TANG Shun-li2 SUN Gang2
1.Department of Urinary Surgery,the Sixth Affiliated Hospital of Guangzhou Medical University,Guangdong Province,Qingyuan 511518,China;
2.Department of Urinary Surgery,Zhongshan Hospital Affiliated to Guangdong Medical University,Guangdong Province,Zhongshan 528415,China
Abstract:Objective To investigate the diagnostic value of prostate specific antigen (PSA)and its related parameters for prostate cancer with PSA<4.0 ng/ml.Methods A total of 320 cases of prostate biopsy with PSA<4.0 ng/ml admitted to the 6th affiliated hospital of Guangzhou medical university and Zhongshan hospital of Guangdong medical university from January to December 2016 were retrospectively analyzed.According to the pathological results of the biopsy,they were divided into 53 cases of prostate cancer(PCA)and 267 cases of benign prostatic hyperplasia (BPH).The total prostate specific antigen(tPSA),free prostate specific antigen(fPSA),f/t PSA and pathological data were collected and divided into 5 intervals of 0.01-0.08,0.09-0.16 and 0.17 according to the f/t PSA ratio.Results There was no significant difference between the two groups in tPSA and fPSA values (P>0.05).The f/t PSA value in PCA group was lower than that in BPH group,the difference was statistically significant(P<0.05).The PCA detection rates of the two groups of patients in f/t PSA 0.09-0.16,0.17-0.24,0.25-0.32 were statistically significant(P<0.05),while the PCA detection rates of the two groups of patients in f/t PSA 0.01-0.08,0.33-0.40 were not statistically significant(P>0.05).Conclusion PSA and PSA-related parameters have a good diagnostic value for the patients with prostate cancer with PSA<4.0 ng/ml.
黄顺坛;唐顺利;孙刚. PSA及相关参数对PSA<4.0 ng/ml前列腺癌的诊断价值[J]. 中国当代医药, 2018, 25(19): 77-79.
HUANG Shun-tan;TANG Shun-li;SUN Gang. Diagnostic value of PSA and related parameters for prostate cancer with PSA<4.0 ng/ml. 中国当代医药, 2018, 25(19): 77-79.
Sokoloff MH,Yang XJ,Fumo M,et al.Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of<4.0 ng/mL[J].BJU Int,2004,93(4):499-502.
[4]
党瑞锋,徐勇,张志宏,等.f/t PSA与PSAD对tPSA灰区前列腺癌诊断价值的 Meta 分析[J].天津医药,2015,40(3):273-276.
[5]
Chen CS,Wang SS,Li JR,et al.PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy[J].J Chin Med Assoc.2011,74(12):552-555.
Whiting PF,Rutjes AW,Westwood ME,et al.QUADAS-2:a revised tool for the quality assessment of diagnostic accuracy studies[J].Ann Intern Med,2011,155(8):529-536.
[8]
孙颖浩.前列腺癌诊治进展[J].上海医学,2011,34(7):487-488.
[9]
Ferreira MD,Koff WJ.Assessment of serum level of prostatespecific antigen adjusted for the transition zone volume in early detection of prostate cancer[J].Int Braz J Urol,2005 Mar-Apr;31(2):137-145.
[10]
Ozen H,Aygün C,Ergen A,et al.Combined use of prostatespecific antigen derivatives decreases the number of unnecessarybiopsies to detect prostate cancer[J].Am J Clin Oncol,2001,24 (6):610-613.
Kandirali E,Boran C,Serin E,et al.Association of extent and aggressiveness of inflammation with serum PSA levels and PSAdensity in asymptomatic patients[J].Urology,2017,70(4):743-747.
[15]
Zheng XY,Xie LP,Wang YY,et al.The use of prostate specific antigen (PSA)density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL[J].J Cancer Res Clin Oncol,2014,134(11):1207-1210.